Journal of Medical Economics, Volume 27, Issue 1 (2024)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Journal of Medical Economics, Volume 27, Issue 1 (2024)

See all volumes and issues
Volume 27, 2024 Vol 26, 2023 Vol 25, 2022 Vol 24, 2021 Vol 23, 2020 Vol 22, 2019 Vol 21, 2018 Vol 20, 2017 Vol 19, 2016 Vol 18, 2015 Vol 17, 2014 Vol 16, 2013 Vol 15, 2012 Vol 14, 2011 Vol 13, 2010 Vol 12, 2009 Vol 11, 2008 Vol 10, 2007 Vol 9, 2006 Vol 8, 2005 Vol 7, 2004 Vol 6, 2003 Vol 5, 2002 Vol 4, 2001 Vol 3, 2000 Vol 2, 1999 Vol 1, 1998
Download citations Download PDFs

Issue In Progress

Covid-19

Review Article
COVID-19 vaccines should be evaluated from the societal perspective
J. P. Sevilla
Pages: 1-9
Published online: 15 Dec 2023
AbstractforCOVID-19 vaccines should be evaluated from the societal perspective | Full Text | References | PDF (505.5 KB) | EPUB
  • 931 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Cardiovascular

Article
Assessment of clinical and economic impact of rivaroxaban plus aspirin vs. aspirin alone as a secondary prophylaxis in patients with chronic and symptomatic peripheral arterial disease in the United States
Anshul Shah, Firas Dabbous, Surbhi Shah, Veronica Ashton & Akshay Kharat
Pages: 10-15
Published online: 09 Dec 2023
AbstractforAssessment of clinical and economic impact of rivaroxaban plus aspirin vs. aspirin alone as a secondary prophylaxis in patients with chronic and symptomatic peripheral arterial disease in the United States | Full Text | References | PDF (518.1 KB) | EPUB | Supplemental
  • 1097 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Women's Health

Article
Evaluating the cost utility of estradiol plus dydrogesterone for the treatment of menopausal women in China
Rautenberg Tamlyn Anne, Martin Downes, Tommaso Simoncini, Qi Yu, Mulan Ren, Yaping Wang, Custodio Marcelo Graziano & Kyoo Kim
Pages: 16-26
Published online: 11 Dec 2023
AbstractforEvaluating the cost utility of estradiol plus dydrogesterone for the treatment of menopausal women in China | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 1276 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Oncology

Article
Cost-effectiveness of volume computed tomography in lung cancer screening: a cohort simulation based on Nelson study outcomes
Xuanqi Pan, Evgeni Dvortsin, David R. Baldwin, Harry J. M. Groen, Dianne Ramaker, James Ryan, Hilde ten Berge, Rimma Velikanova, Matthijs Oudkerk & Maarten J. Postma
Pages: 27-38
Published online: 13 Dec 2023
AbstractforCost-effectiveness of volume computed tomography in lung cancer screening: a cohort simulation based on Nelson study outcomes | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 1582 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

COVID-19

Article
Clinical impact and cost-effectiveness of the updated COVID-19 mRNA Autumn 2023 vaccines in Germany
Keya Joshi, Stefan Scholz, Michael Maschio, Michele Kohli, Amy Lee, Kelly Fust, Bernhard Ultsch, Nicolas Van de Velde & Ekkehard Beck
Pages: 39-50
Published online: 13 Dec 2023
AbstractforClinical impact and cost-effectiveness of the updated COVID-19 mRNA Autumn 2023 vaccines in Germany | Full Text | References | PDF (1.2 MB) | EPUB | Supplemental
  • 1534 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Neurology

Review Article
Economic review of point-of-care EEG
Adam Green, M. Elizabeth Wegman & John P. Ney
Pages: 51-61
Published online: 14 Dec 2023
AbstractforEconomic review of point-of-care EEG | Full Text | References | PDF (778.2 KB) | EPUB | Supplemental
  • 1580 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Cardiovascular

Article
Clinical and economic impact of ventricular assist device infections: a real-world claims analysis
Anton Y. Peleg, Erika D. Feller, Marcus Müller, Sebastian Schulte-Eistrup, David McGiffin, Daniel Zimpfer, Reece Holbrook, Jamie Margetta, Swathi Seshadri & Nahush A. Mokadam
Pages: 62-68
Published online: 18 Dec 2023
AbstractforClinical and economic impact of ventricular assist device infections: a real-world claims analysis | Full Text | References | PDF (903 KB) | EPUB | Supplemental
  • 712 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Health Economics Trends

Article Commentary
What to expect in 2024: important health economics and outcomes research (HEOR) trends
Ivo Abraham, Mickael Hiligsmann, Kenneth K. C. Lee, Leslie Citrome, Giorgio L. Colombo & Mike Gregg
Pages: 69-76
Published online: 20 Dec 2023
First Page PreviewforWhat to expect in 2024: important health economics and outcomes research (HEOR) trends | Full Text | References | PDF (688.9 KB) | EPUB
  • 906 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Oncology

Article
An updated cost-effectiveness analysis of axicabtagene ciloleucel in second-line large B-cell lymphoma patients in the United States
Olalekan O. Oluwole, Anik R. Patel, Sachin Vadgama, Nathaniel J. Smith, Rob Blissett, Chaoling Feng, Michael Dickinson, Patrick B. Johnston & Miguel-Angel Perales
Pages: 77-83
Published online: 19 Dec 2023
AbstractforAn updated cost-effectiveness analysis of axicabtagene ciloleucel in second-line large B-cell lymphoma patients in the United States | Full Text | References | PDF (913.1 KB) | EPUB | Supplemental
  • 1690 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Costs of breast cancer recurrence after initial treatment for HR+, HER2−, high-risk early breast cancer: estimates from SEER-Medicare linked data
Alexandra S. Vitko, Pam Martin, Sheng Zhang, Adam Johnston, Robert Ohsfeldt, Shen Zheng & Astra M. Liepa
Pages: 84-96
Published online: 19 Dec 2023
AbstractforCosts of breast cancer recurrence after initial treatment for HR+, HER2−, high-risk early breast cancer: estimates from SEER-Medicare linked data | Full Text | References | PDF (1.6 MB) | EPUB | Supplemental
  • 1418 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Digital Health

Book Review
The digital transformation of the healthcare system: Healthcare 5.0
by Katarzyna Kolasa, Oxfordshire, Routledge, 190 pp., $46.95 (paperback or eBook), $160.00 (hardcover), ISBN: 9781032413754
C. V. Asche & C. J. Tan
Pages: 97-98
Published online: 20 Dec 2023
CitationforThe digital transformation of the healthcare system: Healthcare 5.0 | Full Text | PDF (146.3 KB) | EPUB
  • 510 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Neurology

Article
A real-world assessment of healthcare costs associated with agitation in Alzheimer’s dementia
George Grossberg, Annette Urganus, Jeff Schein, Rebecca Bungay, Martin Cloutier, Marjolaine Gauthier-Loiselle, Deborah Chan, Annie Guerin & Jyoti Aggarwal
Pages: 99-108
Published online: 26 Dec 2023
AbstractforA real-world assessment of healthcare costs associated with agitation in Alzheimer’s dementia | Full Text | References | PDF (1.2 MB) | EPUB | Supplemental
  • 1242 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom
T. Spelman, W. L. Herring, C. Acosta, R. Hyde, V. G. Jokubaitis, E. Pucci, A. Lugaresi, G. Laureys, E. K. Havrdova, D. Horakova, G. Izquierdo, S. Eichau, S. Ozakbas, R. Alroughani, T. Kalincik, P. Duquette, M. Girard, T. Petersen, F. Patti, T. Csepany, F. Granella, F. Grand’Maison, D. Ferraro, R. Karabudak, M. Jose Sa, M. Trojano, V. van Pesch, B. Van Wijmeersch, E. Cartechini, P. McCombe, O. Gerlach, D. Spitaleri, C. Rozsa, S. Hodgkinson, R. Bergamaschi, R. Gouider, A. Soysal, Castillo-Triviño, J. Prevost, J. Garber, K. de Gans, R. Ampapa, M. Simo, J. L. Sanchez-Menoyo, G. Iuliano, A. Sas, A. van der Walt, N. John, O. Gray, S. Hughes, G. De Luca, M. Onofrj, K. Buzzard, O. Skibina, M. Terzi, M. Slee, C. Solaro, Oreja-Guevara, C. Ramo-Tello, Y. Fragoso, V. Shaygannejad, F. Moore, C. Rajda, E. Aguera Morales & H. Butzkueven
Pages: 109-125
Published online: 26 Dec 2023
AbstractforComparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom | Full Text | References | PDF (1.9 MB) | EPUB | Supplemental
  • 1716 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Sepsis

Article
Cost-effectiveness of intravenous resuscitation fluids in sepsis patients: a patient-level data analysis in Jordan
Shoroq M. Altawalbeh, Eman M. Almestarihi, Rawand A. Khasawneh, Suleiman M. Momany, Khawla Abu Hammour, Mohammad S. Shawaqfeh & Ivo Abraham
Pages: 126-133
Published online: 26 Dec 2023
AbstractforCost-effectiveness of intravenous resuscitation fluids in sepsis patients: a patient-level data analysis in Jordan | Full Text | References | PDF (804.3 KB) | EPUB | Supplemental
  • 786 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Musculoskeletal

Article
Cost-effectiveness analysis of upadacitinib as a treatment option for patients with rheumatoid arthritis in the Kingdom of Saudi Arabia
Hana Al-Abdulkarim, Yuvraj Sharma, Suzan M. Attar, Waleed Husain, Ibrahim Al-Homood, Bedor Al Omari, Omneya Mohamed, Mai Alsaqa’aby, Ahmed M. Jaheen, Ali Anwar, Tharwat M. Hamad & Zeyad Alzahrani
Pages: 134-144
Published online: 01 Jan 2024
AbstractforCost-effectiveness analysis of upadacitinib as a treatment option for patients with rheumatoid arthritis in the Kingdom of Saudi Arabia | Full Text | References | PDF (1.3 MB) | EPUB | Supplemental
  • 1613 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Oncology

Article
Adverse events and costs among non-metastatic castration-resistant prostate cancer patients
Sreevalsa Appukkuttan, Jianying Yao, Jamie Partridge, Sheldon X. Kong, Jacqueline Parkin & Stephen J. Freedland
Pages: 145-152
Published online: 08 Jan 2024
AbstractforAdverse events and costs among non-metastatic castration-resistant prostate cancer patients | Full Text | References | PDF (899.1 KB) | EPUB | Supplemental
  • 1017 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Correction

Correction
Correction
Page: 153
Published online: 10 Jan 2024
CitationforCorrection | Full Text | PDF (145.1 KB) | EPUB
  • 226 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Urology

Article
Cost-effectiveness of a novel urethral catheter safety device in preventing catheterization injuries in the UK
Stefanie M. Croghan, Robert Malcolm, Hugh D. Flood, Stuart Mealing, Brooke Avey, Gavin Leonard, James Wright, Niall F. Davis & Michael T. Walsh
Pages: 154-164
Published online: 10 Jan 2024
AbstractforCost-effectiveness of a novel urethral catheter safety device in preventing catheterization injuries in the UK | Full Text | References | PDF (1,017.8 KB) | EPUB | Supplemental
  • 701 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Correction

Correction
Correction
Pages: 165-166
Published online: 13 Jan 2024
CitationforCorrection | Full Text | PDF (266.5 KB) | EPUB
  • 259 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Digital Health

Editorial
Why are digital health policies crucial?
Ahmad Z. Al Meslamani
Pages: 167-169
Published online: 18 Jan 2024
First Page PreviewforWhy are digital health policies crucial? | Full Text | References | PDF (303 KB) | EPUB
  • 929 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Reproductive Medicine

Article
A cost-effectiveness analysis of intrauterine spacers used to prevent the formation of intrauterine adhesions following endometrial cavity surgery
Luke Schmerold, Coby Martin, Aashay Mehta, Dhruv Sobti, Ajit Kumar Jaiswal, Jatinder Kumar, Ian Feldberg, Malcolm G. Munro & Won Chan Lee
Pages: 170-183
Published online: 30 Jan 2024
AbstractforA cost-effectiveness analysis of intrauterine spacers used to prevent the formation of intrauterine adhesions following endometrial cavity surgery | Full Text | References | PDF (1.4 MB) | EPUB | Supplemental
  • 776 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Infectious Diseases

Review Article
Impact of Ebola epidemics on the daily operation of existing systems in Eastern Democratic Republic of the Congo: a brief review
Daniel Mukadi-Bamuleka, Antoine Nkuba-Ndaye, Placide Mbala-Kingebeni, Steve Ahuka-Mundeke & Jean-Jacques Muyembe-Tamfum
Pages: 184-192
Published online: 22 Jan 2024
AbstractforImpact of Ebola epidemics on the daily operation of existing systems in Eastern Democratic Republic of the Congo: a brief review | Full Text | References | PDF (595.7 KB) | EPUB
  • 956 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Oncology

Article
Validation of overall survival extrapolations made by TLV in the assessment of cost-effectiveness of oncology drugs in Sweden – A pilot study comparing extrapolated and observed life-years gained
Jonas Björnerstedt, Hannah Almqvist, Douglas Lundin & Niklas Zethraeus
Pages: 193-200
Published online: 29 Jan 2024
AbstractforValidation of overall survival extrapolations made by TLV in the assessment of cost-effectiveness of oncology drugs in Sweden – A pilot study comparing extrapolated and observed life-years gained | Full Text | References | PDF (956.4 KB) | EPUB
  • 429 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Real-world economic burden of metastatic castration-resistant prostate cancer before and after first-line therapy initiation
Deborah R. Kaye, Ibrahim Khilfeh, Erik Muser, Laura Morrison, Frederic Kinkead, Ana Urosevic, Patrick Lefebvre, Dominic Pilon & Daniel J. George
Pages: 201-214
Published online: 02 Feb 2024
AbstractforReal-world economic burden of metastatic castration-resistant prostate cancer before and after first-line therapy initiation | Full Text | References | PDF (1.6 MB) | EPUB | Supplemental
  • 1076 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Health Economics

Editorial
Challenges in health economics research: insights from real-world examples
Ahmad Z. Al Meslamani
Pages: 215-218
Published online: 06 Feb 2024
First Page PreviewforChallenges in health economics research: insights from real-world examples | Full Text | References | PDF (290 KB) | EPUB
  • 791 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Oncology

Article
Real world treatment patterns, healthcare resource use and costs in patients with advanced or metastatic non-small cell lung cancer by EGFR mutation type
Pratyusha Vadagam, Dexter Waters, Inyoung Lee, Justin Chen, Dajun Tian, Aimee M. Near, Derek Lyle & Julie Vanderpoel
Pages: 219-229
Published online: 13 Feb 2024
AbstractforReal world treatment patterns, healthcare resource use and costs in patients with advanced or metastatic non-small cell lung cancer by EGFR mutation type | Full Text | References | PDF (1.5 MB) | EPUB | Supplemental
  • 857 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Cost-effectiveness of axicabtagene ciloleucel versus tisagenlecleucel for the treatment of 3L + relapsed/refractory large B-cell lymphoma in the United States: incorporating longer survival results
Olalekan O. Oluwole, Markqayne D. Ray, Neil Davies, Rory Bradford, Calum Jones, Anik R. Patel & Frederick L. Locke
Pages: 230-239
Published online: 13 Feb 2024
AbstractforCost-effectiveness of axicabtagene ciloleucel versus tisagenlecleucel for the treatment of 3L + relapsed/refractory large B-cell lymphoma in the United States: incorporating longer survival results | Full Text | References | PDF (1 MB) | EPUB | Supplemental
  • 1082 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Infectious Diseases

Article
Reduced mortality, complications, and economic burden among medicare beneficiaries receiving influenza antivirals
Jennie H. Best, Sheila R. Reddy, Eunice Chang, Katalin Bognar, Marian H. Tarbox, Steven E. Cagas & Arpamas Seetasith
Pages: 240-252
Published online: 13 Feb 2024
AbstractforReduced mortality, complications, and economic burden among medicare beneficiaries receiving influenza antivirals | Full Text | References | PDF (1.3 MB) | EPUB
  • 383 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Nephrology

Article
Cost-effectiveness analysis of sodium zirconium cyclosilicate for hyperkalemia among patients with chronic kidney disease or heart failure in Kuwait
Gihan Hamdy Elsisi, Mohamed M. Ibrahim Mahmoud, Khaldoon Al-Humood & Anas Al-Yousef
Pages: 253-265
Published online: 14 Feb 2024
AbstractforCost-effectiveness analysis of sodium zirconium cyclosilicate for hyperkalemia among patients with chronic kidney disease or heart failure in Kuwait | Full Text | References | PDF (1.5 MB) | EPUB | Supplemental
  • 1217 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Correction

Correction
Correction
Page: 266
Published online: 20 Feb 2024
CitationforCorrection | Full Text | PDF (144.9 KB) | EPUB
  • 81 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

COVID-19

Review Article
Economic burden of COVID-19 for employers and employees in the United States
Heather Sell, Kassandra Schaible, Julie A. Gouveia-Pisano, Alon Yehoshua, Deepa Malhotra, Manuela Di Fusco, Ashley S. Cha-Silva, Kathleen M. Andersen, Lance Nicholls, Suzanne N. Landi, Catherine Rolland & Jennifer Judy
Pages: 267-278
Published online: 24 Feb 2024
AbstractforEconomic burden of COVID-19 for employers and employees in the United States | Full Text | References | PDF (1.2 MB) | EPUB | Supplemental
  • 1055 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Oncology

Article
Cost-effectiveness of pembrolizumab for previously treated MSI-H/dMMR solid tumours in the UK
Grant McCarthy, Kate Young, Matthew Madin-Warburton, Tyler Mantaian, Elizabeth Brook, Kaylie Metcalfe, Jan Mikelson, Ruifeng Xu, Carl Seyla-Hammer, Raquel Aguiar-Ibáñez & Mayur Amonkar
Pages: 279-291
Published online: 19 Feb 2024
AbstractforCost-effectiveness of pembrolizumab for previously treated MSI-H/dMMR solid tumours in the UK | Full Text | References | PDF (1.8 MB) | EPUB | Supplemental
  • 945 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Cost of genetic testing, delayed care, and suboptimal treatment associated with polymerase chain reaction versus next-generation sequencing biomarker testing for genomic alterations in metastatic non-small cell lung cancer
Christine M. Bestvina, Dexter Waters, Laura Morrison, Bruno Emond, Marie-Hélène Lafeuille, Annalise Hilts, Patrick Lefebvre, Andy He & Julie Vanderpoel
Pages: 292-303
Published online: 24 Feb 2024
AbstractforCost of genetic testing, delayed care, and suboptimal treatment associated with polymerase chain reaction versus next-generation sequencing biomarker testing for genomic alterations in metastatic non-small cell lung cancer | Full Text | References | PDF (1.7 MB) | EPUB | Supplemental
  • 554 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Artificial Intelligence

Editorial
Insights into artificial intelligence utilisation in drug discovery
Abdallah Abou Hajal & Ahmad Z. Al Meslamani
Pages: 304-308
Published online: 22 Feb 2024
First Page PreviewforInsights into artificial intelligence utilisation in drug discovery | Full Text | References | PDF (577.6 KB) | EPUB
  • 791 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Ebola

Article
The economic burden of Ebola virus disease: a review and recommendations for analysis
Mavis Obeng-Kusi, Jennifer Martin & Ivo Abraham
Pages: 309-323
Published online: 23 Feb 2024
AbstractforThe economic burden of Ebola virus disease: a review and recommendations for analysis | Full Text | References | PDF (841.3 KB) | EPUB | Supplemental
  • 844 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Infectious Diseases

Article
Economic burden and secondary complications of influenza-related hospitalization among adults in the US: a retrospective cohort study
Tianyan Hu, Amanda C. Miles, Taryn Pond, Constantina Boikos, Farzaneh Maleki, Tamuno Alfred, Santiago M. C. Lopez & Leah McGrath
Pages: 324-336
Published online: 22 Feb 2024
AbstractforEconomic burden and secondary complications of influenza-related hospitalization among adults in the US: a retrospective cohort study | Full Text | References | PDF (891 KB) | EPUB | Supplemental
  • 805 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Cardiovascular

Article
A matching-adjusted indirect comparison of results from REDUCE and RESPECT—two randomized trials on patent foramen ovale closure devices to prevent recurrent cryptogenic stroke
Scott E. Kasner, Lars Sondergaard, Mitesh Nakum, Melissa Gomez Montero, Mahmoud Hashim & Erik J. Landaas
Pages: 337-343
Published online: 29 Feb 2024
AbstractforA matching-adjusted indirect comparison of results from REDUCE and RESPECT—two randomized trials on patent foramen ovale closure devices to prevent recurrent cryptogenic stroke | Full Text | References | PDF (609.1 KB) | EPUB
  • 723 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Value Based Pricing

Editorial
Value-based pricing: a potential solution to difficult pricing discussions and payers’ negotiations
G. Tremblay, A. Poirier & L. Monfort
Pages: 344-347
Published online: 11 Mar 2024
First Page PreviewforValue-based pricing: a potential solution to difficult pricing discussions and payers’ negotiations | Full Text | References | PDF (478.2 KB) | EPUB
  • 644 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Oncology

Article
Integrated budget impact model to estimate the impact of introducing selpercatinib as a tumor-agnostic treatment option for patients with RET-altered solid tumors in the US
Naleen Raj Bhandari, Adrienne M. Gilligan, Julie Myers, Amine Ale-Ali & Lee Smolen
Pages: 348-358
Published online: 06 Mar 2024
AbstractforIntegrated budget impact model to estimate the impact of introducing selpercatinib as a tumor-agnostic treatment option for patients with RET-altered solid tumors in the US | Full Text | References | PDF (1.4 MB) | EPUB | Supplemental
  • 731 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Diabetes

Editorial
Eliciting health state utilities in Japanese diabetic and obese patients through the time trade-off method. Does the conjecture fat and happy stand true?
Panagiotis Petrou
Pages: 359-360
Published online: 11 Mar 2024
CitationforEliciting health state utilities in Japanese diabetic and obese patients through the time trade-off method. Does the conjecture fat and happy stand true? | Full Text | References | PDF (293.3 KB) | EPUB
  • 277 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Oncology

Article
Treatment patterns and healthcare resource utilization in patients with metastatic hormone-sensitive prostate cancer and nonmetastatic castration-resistant prostate cancer in China: a real-world observational study
Yong Wang, Chunxiao Liu, Chuan Liu, Yongji Lu, Lu Ban & Yuanjie Niu
Pages: 361-369
Published online: 11 Mar 2024
AbstractforTreatment patterns and healthcare resource utilization in patients with metastatic hormone-sensitive prostate cancer and nonmetastatic castration-resistant prostate cancer in China: a real-world observational study | Full Text | References | PDF (1.4 MB) | EPUB | Supplemental
  • 790 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Diabetes

Article
Health state utilities associated with weight loss: preferences of people with type 2 diabetes and obesity in Japan
Louis S. Matza, Katie D. Stewart, Josefine Redig, Timothy A. Howell, Walter Morris, Rachel S. Newson, Alexander Yasui, Jack Ishak & Kristina S. Boye
Pages: 370-380
Published online: 11 Mar 2024
AbstractforHealth state utilities associated with weight loss: preferences of people with type 2 diabetes and obesity in Japan | Full Text | References | PDF (822.7 KB) | EPUB
  • 500 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access

Oncology

Article
Characterizing the real-world economic burden of metastatic castration-sensitive prostate cancer in the United States
Deborah R. Kaye, Ibrahim Khilfeh, Erik Muser, Laura Morrison, Frederic Kinkead, Patrick Lefebvre, Dominic Pilon & Daniel George
Pages: 381-391
Published online: 11 Mar 2024
AbstractforCharacterizing the real-world economic burden of metastatic castration-sensitive prostate cancer in the United States | Full Text | References | PDF (1.2 MB) | EPUB | Supplemental
  • 720 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Hematology

Article
Cost-utility analysis of ferric derisomaltose versus ferric carboxymaltose in patients with inflammatory bowel disease and iron deficiency anemia in England
Tariq H. Iqbal, Nicholas Kennedy, Anjan Dhar, Waqas Ahmed & Richard F. Pollock
Pages: 392-403
Published online: 11 Mar 2024
AbstractforCost-utility analysis of ferric derisomaltose versus ferric carboxymaltose in patients with inflammatory bowel disease and iron deficiency anemia in England | Full Text | References | PDF (1.9 MB) | EPUB | Supplemental
  • 1207 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Cardiovascular

Article
Cost‑effectiveness of add‑on dapagliflozin for heart failure with reduced ejection fraction patients without diabetes
Dina Abushanab, Salma Chbib, Rasha Kaddoura, Moza Al Hail, Palli Valappila Abdul Rouf, Wessam El Kassem, Jassim Shah, Ramesh Kumar Ravindran Nair & Daoud Al-Badriyeh
Pages: 404-417
Published online: 11 Mar 2024
AbstractforCost‑effectiveness of add‑on dapagliflozin for heart failure with reduced ejection fraction patients without diabetes | Full Text | References | PDF (1.3 MB) | EPUB | Supplemental
  • 713 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Diabetes

Article
Budget impact analysis for three glucagon-like peptide-1 receptor agonist-based therapies for type 2 diabetes mellitus management in Saudi Arabia
Hussain A. Al-Omar, Hind S. Almodaimegh, Abubker Omaer, Lamya M. Alzubaidi, Bandar Al-Harbi, Ibtisam Al-Harbi, Mohamed Hassan & Omar Akhtar
Pages: 418-429
Published online: 11 Mar 2024
AbstractforBudget impact analysis for three glucagon-like peptide-1 receptor agonist-based therapies for type 2 diabetes mellitus management in Saudi Arabia | Full Text | References | PDF (1.7 MB) | EPUB
  • 1322 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Infectious Diseases

Article
A cost-consequence analysis of the Xpert Xpress CoV-2/Flu/RSV plus test strategy for the diagnosis of influenza-like illnesses
Shawn Davies, Emily Boller, Jordan Chase, Anne Beaubrun, Cynthia Miller & Ivar Jensen
Pages: 430-441
Published online: 11 Mar 2024
AbstractforA cost-consequence analysis of the Xpert Xpress CoV-2/Flu/RSV plus test strategy for the diagnosis of influenza-like illnesses | Full Text | References | PDF (995.7 KB) | EPUB | Supplemental
  • 1501 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Migraine

Editorial
Placebo responses vary by route of administration in migraine prevention trials. What does this mean?
Christina I. Deligianni, Paolo Martelletti & Dimos D. Mitsikostas
Pages: 442-444
Published online: 12 Mar 2024
First Page PreviewforPlacebo responses vary by route of administration in migraine prevention trials. What does this mean? | Full Text | References | PDF (304.9 KB) | EPUB | Supplemental
  • 330 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Oncology

Article
A cost-consequence model of using the 21-gene assay to identify patients with early-stage node-positive breast cancer who benefit from adjuvant chemotherapy in the Netherlands
Martijn J. H. G. Simons, Peter M. Machielsen, Jelle A. Spoorendonk, Tim Ignacio, Pieter B. Drost, Tim Jacobs & Felix E. de Jongh
Pages: 445-454
Published online: 12 Mar 2024
AbstractforA cost-consequence model of using the 21-gene assay to identify patients with early-stage node-positive breast cancer who benefit from adjuvant chemotherapy in the Netherlands | Full Text | References | PDF (1.2 MB) | EPUB | Supplemental
  • 542 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Nephrology

Article
The burden of end-stage renal disease in Khartoum, Sudan: cost of illness study
Hiba Ali Hajomer, Osama Ahmed Elkhidir, Shaima Omer Elawad, Ola Hatim Elniema, Mustafa Khalid Khalid, Lina S. Altayib, Ibrahim Ahmed Abdalla & Tahani Amin Mahmoud
Pages: 455-462
Published online: 17 Mar 2024
AbstractforThe burden of end-stage renal disease in Khartoum, Sudan: cost of illness study | Full Text | References | PDF (647.8 KB) | EPUB
  • 583 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Cardiovascular

Article
Post-approval indications and clinical trials for cardiovascular drugs: some implications of the US Inflation Reduction Act
Henry Grabowski & Genia Long
Pages: 463-472
Published online: 18 Mar 2024
AbstractforPost-approval indications and clinical trials for cardiovascular drugs: some implications of the US Inflation Reduction Act | Full Text | References | PDF (728.6 KB) | EPUB | Supplemental
  • 1220 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Oncology

Research Letter
Challenges, considerations, and approaches for developing a cost-effectiveness model for the adjuvant treatment of muscle-invasive urothelial carcinoma: with a spotlight on nivolumab versus placebo
Siguroli Teitsson, Thor-Henrik Brodtkorb, Murat Kurt, Miraj Y. Patel, Tayla Poretta, Christopher Knight, Farzam Kamgar & Stephen Palmer
Pages: 473-481
Published online: 25 Mar 2024
AbstractforChallenges, considerations, and approaches for developing a cost-effectiveness model for the adjuvant treatment of muscle-invasive urothelial carcinoma: with a spotlight on nivolumab versus placebo | Full Text | References | PDF (777.8 KB) | EPUB | Supplemental
  • 502 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access

Correction

Correction
Correction
Page: 482
Published online: 30 Apr 2024
CitationforCorrection | Full Text | PDF (162.2 KB) | EPUB
  • 38 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Oncology

Article
Cost effectiveness of pembrolizumab plus lenvatinib compared with chemotherapy for treating previously treated advanced endometrial cancer in Sweden
Lewis Ralph, Kate Young, Navneet Upadhyay, Vimalanand Shrikant Prabhu, Christina Ljungcrantz, Rachid Massaad, Ruifeng Xu, Anna Giertz, Adil Merchant, Robert Orlowski & Linda Duska
Pages: 483-491
Published online: 26 Mar 2024
AbstractforCost effectiveness of pembrolizumab plus lenvatinib compared with chemotherapy for treating previously treated advanced endometrial cancer in Sweden | Full Text | References | PDF (905 KB) | EPUB | Supplemental
  • 786 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Mental Health

Article
The cost-effectiveness of zuranolone versus selective serotonin reuptake inhibitors for the treatment of postpartum depression in the United States
Lasair O’Callaghan, Elizabeth Chertavian, Scott J. Johnson, Erin Ferries & Kristina M. Deligiannidis
Pages: 492-505
Published online: 31 Mar 2024
AbstractforThe cost-effectiveness of zuranolone versus selective serotonin reuptake inhibitors for the treatment of postpartum depression in the United States | Full Text | References | PDF (1.2 MB) | EPUB
  • 1188 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Neurology

Article
Quantifying preferences for urea cycle disorder treatments using a discrete choice experiment
Josiah Edelblut, Jeffrey R. Skaar, John Hilton, Matthew Seibt, Kyle Martin, Nandini Hadker, Adrian Quartel & Robert D. Steiner
Pages: 506-517
Published online: 31 Mar 2024
AbstractforQuantifying preferences for urea cycle disorder treatments using a discrete choice experiment | Full Text | References | PDF (2.3 MB) | EPUB | Supplemental
  • 352 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Addendum

Addendum
Addendum
Page: 518
Published online: 02 Apr 2024
CitationforAddendum | Full Text | PDF (144.1 KB) | EPUB
  • 72 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Oncology

Article
Value of next generation sequencing (NGS) testing in advanced cancer patients
Jesse D. Ortendahl, Gebra Cuyun Carter, Snehal G. Thakkar, Katalin Bognar, David W. Hall & Yara Abdou
Pages: 519-530
Published online: 02 Apr 2024
AbstractforValue of next generation sequencing (NGS) testing in advanced cancer patients | Full Text | References | PDF (1,012.7 KB) | EPUB | Supplemental
  • 826 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Healthcare resource utilization and associated costs in patients with metastatic urothelial carcinoma: a real-world analysis using German claims data
Günter Niegisch, Marc-Oliver Grimm, Fraence Hardtstock, Julia Krieger, Alexandra Starry, Ulrike Osowski, Barthold Deiters, Ulf Maywald, Thomas Wilke & Mairead Kearney
Pages: 531-542
Published online: 19 Apr 2024
AbstractforHealthcare resource utilization and associated costs in patients with metastatic urothelial carcinoma: a real-world analysis using German claims data | Full Text | References | PDF (1.4 MB) | EPUB | Supplemental
  • 322 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Cost-effectiveness of nivolumab versus surveillance for the adjuvant treatment of patients with urothelial carcinoma who are at high risk of recurrence: a US payer perspective
Thor-Henrik Brodtkorb, Christopher Knight, Farzam Kamgar, Siguroli Teitsson, Murat Kurt, Miraj Y. Patel, Tayla Poretta, Ronac Mamtani & Stephen Palmer
Pages: 543-553
Published online: 04 Apr 2024
AbstractforCost-effectiveness of nivolumab versus surveillance for the adjuvant treatment of patients with urothelial carcinoma who are at high risk of recurrence: a US payer perspective | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 586 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access

Urology

Article
Cost-effectiveness analysis of minimally invasive surgical treatments for benign prostatic hyperplasia: implications for Japan’s public healthcare system
Hisataka Anezaki, Fumiyasu Endo, Georgia Swan, Kenta Takashima & Sirikan Rojanasarot
Pages: 554-565
Published online: 08 Apr 2024
AbstractforCost-effectiveness analysis of minimally invasive surgical treatments for benign prostatic hyperplasia: implications for Japan’s public healthcare system | Full Text | References | PDF (1.9 MB) | EPUB
  • 672 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Gastroenterology

Article
Assessing the economics of biologic and small molecule therapies for the treatment of moderate to severe ulcerative colitis in Japan: a cost per responder analysis of upadacitinib
Masayuki Saruta, Isao Kawaguchi, Yuji Ogawa, Yuri Sanchez Gonzalez, Naoki Numajiri, Xiaohe Tang & Russell Miller
Pages: 566-574
Published online: 05 Apr 2024
AbstractforAssessing the economics of biologic and small molecule therapies for the treatment of moderate to severe ulcerative colitis in Japan: a cost per responder analysis of upadacitinib | Full Text | References | PDF (955.4 KB) | EPUB | Supplemental
  • 980 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Cardiovascular

Article
Cost effectiveness of implantable cardioverter defibrillators for 1.5 primary prevention of sudden cardiac arrest in China: an analysis from the Improve SCA study
Hui Sun, Xin Liu, Jin Fu, Yin Song, Xiaoxiao Qin & Haiyin Wang
Pages: 575-581
Published online: 08 Apr 2024
AbstractforCost effectiveness of implantable cardioverter defibrillators for 1.5 primary prevention of sudden cardiac arrest in China: an analysis from the Improve SCA study | Full Text | References | PDF (779.8 KB) | EPUB
  • 226 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Mental Health

Article
Indirect comparisons of relative efficacy estimates of zuranolone and selective serotonin reuptake inhibitors for postpartum depression
Samantha Meltzer-Brody, Margaret E. Gerbasi, Catherine Mak, Youssef Toubouti, Sarah Smith, Neil Roskell, Robin Tan, Shih-Yin (Sharon) Chen & Kristina M. Deligiannidis
Pages: 582-595
Published online: 15 Apr 2024
AbstractforIndirect comparisons of relative efficacy estimates of zuranolone and selective serotonin reuptake inhibitors for postpartum depression | Full Text | References | PDF (1.5 MB) | EPUB | Supplemental
  • 1096 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access

Cardiovascular

Article
Comparative adherence of macitentan versus ambrisentan and bosentan in Australian patients with pulmonary arterial hypertension: a retrospective real-world database study
Edmund Lau, Eugene Kotlyar, Yogeshwar Makanji, Dae Young Yu, Jin Yu Tan, Jeremy Casorso, Mahsa H. Kouhkamari, Sooyeol Lim, David Bin-Chia Wu & Paul Bloomfield
Pages: 596-604
Published online: 10 Apr 2024
AbstractforComparative adherence of macitentan versus ambrisentan and bosentan in Australian patients with pulmonary arterial hypertension: a retrospective real-world database study | Full Text | References | PDF (874.7 KB) | EPUB | Supplemental
  • 731 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Oncology

Addendum
Addendum
Page: 605
Published online: 12 Apr 2024
CitationforAddendum | Full Text | PDF (144 KB) | EPUB
  • 85 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Correction

Correction
Correction
Page: 606
Published online: 10 Apr 2024
CitationforCorrection | Full Text | PDF (167.7 KB) | EPUB
  • 62 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Cardiovascular

Article
Validity and measurement equivalence of EQ-5D-5L questionnaire among heart failure patients in Malaysia: a cohort study
Wai Chee Kuan, Kok Han Chee, Sazzli Kasim, Ka Keat Lim, Juman Abdulelah Dujaili, Kenneth Kwing-Chin Lee & Siew Li Teoh
Pages: 607-617
Published online: 13 Apr 2024
AbstractforValidity and measurement equivalence of EQ-5D-5L questionnaire among heart failure patients in Malaysia: a cohort study | Full Text | References | PDF (1.3 MB) | EPUB | Supplemental
  • 402 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Nephrolog

Review Article
Exploring kidney dialysis costs in the United States: a scoping review
Fiona Stewart, Kristin Kistler, Yuxian Du, Rakesh R. Singh, Bonnie B. Dean & Sheldon X. Kong
Pages: 618-625
Published online: 25 Apr 2024
AbstractforExploring kidney dialysis costs in the United States: a scoping review | Full Text | References | PDF (868.7 KB) | EPUB | Supplemental
  • 640 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Retraction

Retraction
Statement of Retraction: Hospitalization-related costs associated with oral agents targeting the prostacyclin pathway for pulmonary arterial hypertension
Page: 626
Published online: 18 Apr 2024
CitationforStatement of Retraction: Hospitalization-related costs associated with oral agents targeting the prostacyclin pathway for pulmonary arterial hypertension | Full Text | PDF (194.1 KB) | EPUB
  • 184 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Migraine

Article
Cost-effectiveness of rimegepant oral lyophilisate compared to best supportive care for the acute treatment of migraine in the UK
Karissa Johnston, Lauren C. Powell, Evan Popoff, Gil J. L’Italien, Robert Pawinski, Aideen Ahern, Sam Large, Thang Tran & Aaron Jenkins
Pages: 627-643
Published online: 27 Apr 2024
AbstractforCost-effectiveness of rimegepant oral lyophilisate compared to best supportive care for the acute treatment of migraine in the UK | Full Text | References | PDF (2.1 MB) | EPUB | Supplemental
  • 622 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Infectious Diseases

Article
Cost-effectiveness and impact on infections and associated antimicrobial resistance of 20-valent pneumococcal conjugate vaccine in US children previously immunized with PCV13
Mark H. Rozenbaum, Liping Huang, Alejandro Cane, Adriano Arguedas, Ruth Chapman, Desmond Dillon-Murphy, Maria J. Tort, Vincenza Snow, Erica Chilson & Raymond Farkouh
Pages: 644-652
Published online: 19 Apr 2024
AbstractforCost-effectiveness and impact on infections and associated antimicrobial resistance of 20-valent pneumococcal conjugate vaccine in US children previously immunized with PCV13 | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 495 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Mental Health

Article
Costs associated with adverse events during treatment episodes for adult attention-deficit/hyperactivity disorder
Jeff Schein, Martin Cloutier, Rebecca Bungay, Marjolaine Gauthier-Loiselle & Ann Childress
Pages: 653-662
Published online: 27 Apr 2024
AbstractforCosts associated with adverse events during treatment episodes for adult attention-deficit/hyperactivity disorder | Full Text | References | PDF (1.4 MB) | EPUB | Supplemental
  • 441 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Nephrology

Article
Clinical and economic outcomes of assigning percutaneous coronary intervention patients to contrast-sparing strategies based on the predicted risk of contrast-induced acute kidney injury
Robert I. Griffiths, Aparna Bhave, Alysha M. McGovern, Liesl M. Hargens, Craig A. Solid & Amit P. Amin
Pages: 663-670
Published online: 22 Apr 2024
AbstractforClinical and economic outcomes of assigning percutaneous coronary intervention patients to contrast-sparing strategies based on the predicted risk of contrast-induced acute kidney injury | Full Text | References | PDF (1 MB) | EPUB | Supplemental
  • 268 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Respiratory Medicine

Article
Impact of Pseudomonas aeruginosa on resource utilization and costs in patients with exacerbated non-cystic fibrosis bronchiectasis
Meg Franklin, Michael E. Minshall, Federica Pontenani & Sunjay Devarajan
Pages: 671-677
Published online: 27 Apr 2024
AbstractforImpact of Pseudomonas aeruginosa on resource utilization and costs in patients with exacerbated non-cystic fibrosis bronchiectasis | Full Text | References | PDF (753.2 KB) | EPUB
  • 349 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Genetic Disease

Editorial
Value-based payment and financing for cell and gene therapies: challenges and potential solutions
James X. Zhang & Lisa R. Shugarman
Pages: 678-681
Published online: 27 Apr 2024
First Page PreviewforValue-based payment and financing for cell and gene therapies: challenges and potential solutions | Full Text | References | PDF (335.6 KB) | EPUB
  • 324 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Musculoskeletal

Article
The cost-effectiveness of a bimekizumab versus IL-17A inhibitors treatment-pathway in patients with active axial spondyloarthritis in Scotland
Michael F. Mørup, Vanessa Taieb, Damon Willems, Micah Rose, Nikos Lyris, Mark Lamotte, Laetitia Gerlier & Howard Thom
Pages: 682-696
Published online: 02 May 2024
AbstractforThe cost-effectiveness of a bimekizumab versus IL-17A inhibitors treatment-pathway in patients with active axial spondyloarthritis in Scotland | Full Text | References | PDF (1.4 MB) | EPUB | Supplemental
  • 447 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Cardiovascular

Article
Cost-effectiveness analysis of transcatheter aortic valve implantation in aortic stenosis patients at low- and intermediate-surgical risk in Japan
Junjiro Kobayashi, Suzanne J. Baron, Kensuke Takagi, Christin A. Thompson, Xiayu Jiao & Kaoru Yamabe
Pages: 697-707
Published online: 06 May 2024
AbstractforCost-effectiveness analysis of transcatheter aortic valve implantation in aortic stenosis patients at low- and intermediate-surgical risk in Japan | Full Text | References | PDF (1.5 MB) | EPUB | Supplemental
  • 364 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Respiratory

Article
Economic impact analysis of a minimally invasive temperature-controlled radiofrequency device versus nasal surgery for the treatment of nasal airway obstruction in the United States
Michael Yong, Desiree Hollemon, Julie Baxter, Alex Hirst, Sam Bryning, Aimee Fox, Greg Smith, Robert Hughes, Giulia Brandolini, Scott Wolf & Randall Ow
Pages: 708-714
Published online: 09 May 2024
AbstractforEconomic impact analysis of a minimally invasive temperature-controlled radiofrequency device versus nasal surgery for the treatment of nasal airway obstruction in the United States | Full Text | References | PDF (753 KB) | EPUB | Supplemental
  • 341 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Cardiovascular

Article
Economic and healthcare resource utilization assessments of PET imaging in Coronary Artery Disease diagnosis: a systematic review and discussion of opportunities for future economic evaluations
Nicole Ferko, Stacey Priest, Lamees Almuallem, Alicyia Walczyk Mooradally, Di Wang, Abril Oliva Ramirez, Erika Szabo & Arturo Cabra
Pages: 715-729
Published online: 06 May 2024
AbstractforEconomic and healthcare resource utilization assessments of PET imaging in Coronary Artery Disease diagnosis: a systematic review and discussion of opportunities for future economic evaluations | Full Text | References | PDF (1.2 MB) | EPUB | Supplemental
  • 312 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Immunology

Article
A comparison of healthcare utilization and outcomes following skin vs. serum-specific IgE allergy testing
Yang Z. Lu & Kenny Yat-Choi Kwong
Pages: 730-737
Published online: 09 May 2024
AbstractforA comparison of healthcare utilization and outcomes following skin vs. serum-specific IgE allergy testing | Full Text | References | PDF (771.5 KB) | EPUB
  • 242 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Oncology

Article
Real-world total cost of care by line of therapy in relapsed/refractory diffuse large B-cell lymphoma
Justin Gatwood, Anthony Masaquel, David Fox, Daniel Sheinson, Cameron James, Jia Li, Farah Hossain & Ryan Ross
Pages: 738-745
Published online: 06 May 2024
AbstractforReal-world total cost of care by line of therapy in relapsed/refractory diffuse large B-cell lymphoma | Full Text | References | PDF (1 MB) | EPUB | Supplemental
  • 395 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Estimated impact and value of blood-based colorectal cancer screening at varied adherence compared with stool-based screening
John B. Kisiel, A. Mark Fendrick, Derek W. Ebner, A. Burak Ozbay, Vahab Vahdat, Chris Estes & Paul J. Limburg
Pages: 746-753
Published online: 13 May 2024
AbstractforEstimated impact and value of blood-based colorectal cancer screening at varied adherence compared with stool-based screening | Full Text | References | PDF (905.8 KB) | EPUB | Supplemental
  • 491 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

AI

Editorial
Balancing innovation and ethics in AI governance for health technology assessment
João L. Carapinha, Danélia Botes & René Carapinha
Pages: 754-757
Published online: 13 May 2024
First Page PreviewforBalancing innovation and ethics in AI governance for health technology assessment | Full Text | References | PDF (388.9 KB) | EPUB
  • 337 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Explore articles

Explore the most recently published articles

The efficiency of TAVI in intermediate and low-risk Japanese patients.
Panagiotis Petrou
Editorial | Published online: 25 May 2024
Open Access
Cost-effectiveness of empagliflozin as add-on to standard of care for chronic kidney disease management in the United Kingdom
Mafalda Ramos et al.
Article | Published online: 17 May 2024
Open Access
Estimated impact and value of blood-based colorectal cancer screening at varied adherence compared with stool-based screening
John B. Kisiel et al.
Article | Published online: 13 May 2024
Open Access
Balancing innovation and ethics in AI governance for health technology assessment
João L. Carapinha et al.
Editorial | Published online: 13 May 2024
Open Access
View all latest articles